Article
miR-30b-5p inhibits osteoblast differentiation through targeting BCL6
31 Jan 2022
Abstract excerpt
Human bone marrow mesenchymal stem cells (hBMSCs) are attractive candidates for new therapies to improve bone regeneration and repair. This study was to identify the function of the miR-30b-5p/BCL6 axis in osteogenic differentiation of hBMSCs. Realtime-quantitative PCR (RT-qPCR) and Western blotting were used to measure the relative expression of ALP, OCN, RUNX2, miR-30b-5p, and BCL6 during osteogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
